Inventor · disambiguated record
Yufeng Shi
Also filed as: SHI YUFENG
3 granted patents·14 pending applications·0 citations·filing 2016–2023
38Inventor score
Files withNANJING SHIJIANG MEDICINE TECH CO LTD8SHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD5CITRIX SYSTEMS INC1JINGDONG TECHNOLOGY INFORMATION TECHNOLOGY CO LTD1NANJIANG SHIJIANG MEDICINE TECH CO LTD1
Top patents by PatentIndex Score
17 records- 0148US12502386B2Nitrogen-containing heterocyclic compound and use thereofSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Granted Dec 23, 2025·0 cites·19 claims
- 0247US2025304608A1Phosphorus compound and use thereofSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0342US2025214993A1Aromatic ring compound and use thereofSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0442US2025195502A1Application of tetracyclic compound in treatment of tumorsSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0540US2025282774A1Fused ring compoundSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 0639US12141747B2Method and apparatus for acquiring inventory data, terminal device and computer-readable storage mediumJINGDONG TECHNOLOGY INFORMATION TECHNOLOGY CO LTD·Filed 2020·Granted Nov 12, 2024·0 cites·14 claims
- 0739US11063935B2Systems and methods for providing remote desktop accessCITRIX SYSTEMS INC·Filed 2018·Granted Jul 13, 2021·0 cites·17 claims
- 0839US2024350478A1Application of benzisoquinoline diketone compound in treatment of tumorNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 0939US2025120946A1Use of pyrrole compound in treatment of tumorsNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 1038US2024350460A1Application of hydrazide compound in tumor treatmentNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 1138US2025000826A1Application of benzanilide compound in tumor treatmentNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 1238US2025268923A1Application of tetracycline compound in treatment of tumorNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2022·Application pending·0 cites
- 1335US2024124445A1Benzene ring compound and use thereofNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
- 1435US2023404996A1Application of isoquinoline compound in tumor treatmentNANJIANG SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
- 1534US2023355647A1Marker for determining anti-cancer effects of mitochondrial oxidative phosphorylation pathway inhibitorNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
- 1634US2018354909A1Substituted benzimidazolium, pyrido-imidazolium, or pyrazino-imidazolium compounds as chemotherapeuticsUNIV TEXAS·Filed 2016·Application pending·0 cites
- 1732US2023098254A1Scutellariae radix compounds and use thereof for inhibiting oxidative phosphorylation pathway of mitochondriaNANJING SHIJIANG MEDICINE TECH CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yufeng Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →